Linked from

The 24 pages that link to Cyclooxygenase, each with the reason it gives.

• Nonsteroidal anti-inflammatory drugRelated: Most NSAIDs reduce prostaglandin production by inhibiting these enzymes.

• AspirinRelated: Aspirin acetylates these enzymes, reducing production of inflammatory mediators and platelet thromboxane.

• ProstaglandinRelated: COX enzymes catalyze the pathway's first committed steps.

• AcetaminophenRelated: Acetaminophen's effects have been linked to cyclooxygenase activity, though it differs from conventional inhibitors.

• AnalgesicRelated: NSAIDs relieve pain partly by inhibiting cyclooxygenase and reducing prostaglandin production.

• Arachidonic acidRelated: This route produces prostaglandins and thromboxanes from arachidonic acid.

• EicosanoidRelated: It starts the pathway that produces prostaglandins and thromboxanes.

• IbuprofenRelated: Ibuprofen reversibly inhibits COX-1 and COX-2, reducing the production of pain- and inflammation-promoting prostaglandins.

• ParacetamolRelated: Paracetamol may reduce prostaglandin production, though its effects on cyclooxygenase remain debated.

• AnalgesiaRelated: Nonsteroidal analgesics reduce prostaglandin production by inhibiting this enzyme.

• AntipyreticRelated: Many antipyretics inhibit these enzymes, reducing fever-promoting prostaglandins.

• DiclofenacRelated: Diclofenac inhibits these enzymes, reducing production of pain- and inflammation-related prostaglandins.

• Omega-6 fatty acidRelated: Cyclooxygenase directs one major route from omega-6 substrate to signaling products.

• Eicosapentaenoic acidRelated: Cyclooxygenase converts EPA into three-series prostanoids.

• Acetylsalicylic acidRelated: Aspirin acetylates cyclooxygenase, reducing production of pain- and inflammation-related mediators.

• NaproxenRelated: Naproxen inhibits these enzymes, reducing prostaglandin production.

• SalicinRelated: Cyclooxygenase inhibition explains much of the pharmacology of salicylate medicines, but not salicin’s entire action.

• MetamizoleRelated: Cyclooxygenase inhibition is one proposed contributor to metamizole’s analgesic and antipyretic effects.

• MesalazineRelated: Inhibition of cyclooxygenase is one proposed contributor to mesalazine’s anti-inflammatory effects.

• ResveratrolRelated: Resveratrol can inhibit cyclooxygenase activity, connecting it to proposed anti-inflammatory effects.

• IndometacinRelated: Indometacin inhibits these enzymes, reducing the production of inflammatory prostaglandins.

• PiroxicamRelated: Piroxicam suppresses these enzymes, reducing prostaglandins that contribute to pain and inflammation.